ArticleBJC reports2026

Molecular targeting of the meningioma cell signaling circuit reveals drug vulnerabilities including synergy between sulforaphane and focal adhesion kinase inhibition.

Michelle C Schwab et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.